Literature DB >> 9113361

Analysis of two pharmacologically predicted endothelin B receptor subtypes by using the endothelin B receptor gene knockout mouse.

T Mizuguchi1, M Nishiyama, K Moroi, H Tanaka, T Saito, Y Masuda, T Masaki, D de Wit, M Yanagisawa, S Kimura.   

Abstract

1. This study was performed to clarify whether the endothelin (ET) receptor subtypes mediating two pharmacologically heterogeneous response to ETH receptor agonists in normal mice are the product(s) of a single ETB receptor gene. 2. Vasodilator responses to sarafotoxin S6c (S6c) in the thoracic aorta and contractile responses to ET-1 and IRL1620 in the stomach were examined in tissues from normal and ETB receptor gene knockout mice, in the absence and presence of an ETA receptor antagonist, BQ-123, or an ETA/ETB receptor antagonist, PD142893. 3. In the normal mouse aorta precontracted with phenylephrine, S6c (0.1-100 nM) caused concentration-dependent relaxations (pD2 = 8.4). BQ-123 had no effect on these responses. However, PD142893 almost abolished the relaxations induced by 0.1-300 nM S6c. 4. In aortae taken from ETB receptor gene knockout mice, S6c up to 1 microM failed to cause relaxations, confirming that ETB receptors are involved in mediating this response. 5. In normal mouse gastric fundus, 0.1 nM-1 microM ET-1, S6c or IRL1620 caused dose-dependent, BQ-123-insensitive contractions, which were much more resistant to PD142893 than S6c-induced relaxations of the aorta. The pD2 values for S6c in the absence and presence of PD142893 (10 microM) were 8.12 +/- 0.11 and 7.70 +/- 0.11, respectively. 6. In the gastric fundus of the ETB receptor gene knockout mouse, S6c and IRL1620 caused no contractions. ET-1 (0.1 nM-1 microM) caused contractions sensitive to both BQ-123 and PD142893, indicating that only ETA receptors mediate ET-1-induced contractions of the knockout mouse gastric fundus. 7. Since both the PD142893-sensitive vasodilator response of the aorta and the PD142893-resistant contractile response of the gastric fundus to S6c were completely absent in the ETB receptor gene knockout mouse, we conclude that the two pharmacologically heterogeneous responses to S6c are mediated by receptors derived from the same ETB receptor gene.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9113361      PMCID: PMC1564617          DOI: 10.1038/sj.bjp.0701054

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  12 in total

Review 1.  Therapeutic role of bosentan in hypertension: lessons from the model of perinephritic hypertension.

Authors:  J E Donckier
Journal:  Heart Fail Rev       Date:  2001-12       Impact factor: 4.214

Review 2.  Endothelin receptors: what's new and what do we need to know?

Authors:  Stephanie W Watts
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-11-11       Impact factor: 3.619

3.  Differential modulation of endothelin ligand-induced contraction in isolated tracheae from endothelin B (ET(B)) receptor knockout mice.

Authors:  D W Hay; S A Douglas; Z Ao; R M Moesker; G J Self; P J Rigby; M A Luttmann; R G Goldie
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

4.  The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

5.  Endothelial endothelin B receptor-mediated prevention of cerebrovascular remodeling is attenuated in diabetes because of up-regulation of smooth muscle endothelin receptors.

Authors:  Aisha I Kelly-Cobbs; Alex K Harris; Mostafa M Elgebaly; Weiguo Li; Kamakshi Sachidanandam; Vera Portik-Dobos; Maribeth Johnson; Adviye Ergul
Journal:  J Pharmacol Exp Ther       Date:  2010-12-23       Impact factor: 4.030

6.  Transcriptional down-regulation of the rabbit pulmonary artery endothelin B receptor during phenotypic modulation.

Authors:  R Owe-Young; C G Schyvens; R A Qasabian; A D Conigrave; P S Macdonald; D J Williamson
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

7.  Effect of chronic endothelin receptor antagonism on cerebrovascular function in type 2 diabetes.

Authors:  Alex K Harris; Mostafa M Elgebaly; Weiguo Li; Kamakshi Sachidanandam; Adviye Ergul
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-02-20       Impact factor: 3.619

8.  Effect of chronic and selective endothelin receptor antagonism on microvascular function in type 2 diabetes.

Authors:  Kamakshi Sachidanandam; Mostafa M Elgebaly; Alex K Harris; Jim R Hutchinson; Erin M Mezzetti; Vera Portik-Dobos; Adviye Ergul
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-04-18       Impact factor: 4.733

Review 9.  The endothelin system as a therapeutic target in cardiovascular disease: great expectations or bleak house?

Authors:  N S Kirkby; P W F Hadoke; A J Bagnall; D J Webb
Journal:  Br J Pharmacol       Date:  2007-10-29       Impact factor: 8.739

Review 10.  Endothelin receptors and pain.

Authors:  Alla Khodorova; Jean-Pierre Montmayeur; Gary Strichartz
Journal:  J Pain       Date:  2009-01       Impact factor: 5.820

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.